Quest Diagnostics Grows On New Pacts Amid Reimbursement Issue
Zacks Investment Research | Mar 24, 2019 10:04PM ET
On Mar 22, we issued an updated research report on Quest Diagnostics, Inc. (NYSE:DGX) . As a part of its two-point strategy, Quest Diagnostics has been focusing on areas with high potential. However, the reimbursement scenario remains a major cause of concern for thisZacks Rank #3 (Hold) company.
Quest Diagnostics is currently focusing on diagnostic information services and disciplined capital deployment. Meanwhile, the company’s acquisitions and collaborations with hospitals and integrated delivery networks act as major growth drivers.
We are upbeat about the company’s partnership with UnitedHealthcare, a business of UnitedHealth Group (NYSE:UNH), to operate as a preferred national laboratory for the latter’s members since Jan 1, 2019.
This agreement will provide in-network access to Quest Diagnostics’ complete portfolio of laboratory services to more than 48 million eligible members. Under the expanded tie-up, the companies are going to collaborate on a variety of value-based programs.
Quest Diagnostics Incorporated Price
Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.